Intracameral tPA can treat fibrinous clots in severe anterior uveitis.
Representatives from Magellan Rx Management provided a detailed overview of current treatment options in ophthalmology and the impact that biosimilars could have.
Physicians can use navigational tools to attain a much more immersive perspective.
Sunil Srivastava, MD, shares his experience using dexamethasone and fluocinolone acetonide implants to manage chronic non-infectious uveitis.
Lens thickness and anterior chamber duct values obtained by Lenstar can be improved by SpikeFinder to reduce errors in measurements.
Papilledema with back pain suggests spine lesion.
Having a comprehensive team of ophthalmic specialists in place means patients could have multiple issues treated in a single procedure that might require two surgeries otherwise.
Adolf Fercher's 2D image of fundus paved way for today’s imaging technique.
Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.
As dexamethasone adds indications, a study confirms efficacy of punctal occlusion for allergic conjunctivitis.
From cytokine pathways to genomics, Shree Kurup, MD, highlights new approaches for managing diabetic retinopathy and combating systemic inflammation.
When it comes to the sexes in the operating room, the key is collaboration, with a goal of presenting patient suffering.
Hyaluronic acid fillers are used for undereye volume correction, detailing aging effects on facial anatomy, common complications, and optimal injection techniques. Imaging tools such as MRI can prove to be beneficial for patient assessment.
Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal disease
Higher levels of 3 macular pigments minimize risk of age-related disease.
Carl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.
Deep learning discerns IIH, NAION, and normal eyes using single fundus image.
At ARVO 2025, in Salt Lake City, Utah, Steven Barnes, PhD, talked about his research on the OPA1 mutation in retinal ganglion cells' effect on the cell's electrical function.
Andrew Iwach, MD, co-founder of the Glaucoma 360 meeting shares that value this meeting has for residents and fellows as they embark on their careers and the future additions to the meeting that will include retina discussions.
Drops can simplify dosing, improving adherence and ocular surface health
Nicole Fram, MD concludes this series on the potential of decentration and subsequent IOLs misalignment, highlighting zero and negative spherical aberration lens options for these unique cases.
Expert panelists provide an overview of current unmet needs in wet AMD care and discuss the potential for improving clinical outcomes and treatment burden.
In this Q&A, John D. Gelles, OD, and Steven Greenstein, MD, chat about what inspired them to launch the symposium, what makes this year’s agenda especially exciting, and why the future of refractive care depends on stronger collaboration between ODs and MDs.
Lori Wright, JD, sat down to talk about a discussion at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Andrew G. Lee, MD, has had direct experience as being an in-flight physician over 15 times on international and domestic flights and answers some of the most frequently asked questions about being the doctor on the plane.
RWO is hosting its 5th virtual, interactive conference titled “Top 10 Things I Wish I Knew Sooner” on Saturday September 30, 2023, from 8 am to 5:30 pm Central Time.